Cargando…
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
BACKGROUND: Failure to clear Aβ from the brain is partly responsible for Aβ brain accumulation in Alzheimer’s disease (AD). A critical protein for clearing Aβ across the blood-brain barrier is the efflux transporter P-glycoprotein (P-gp). In AD, P-gp levels are reduced, which contributes to impaired...
Autores principales: | Ding, Yujie, Zhong, Yu, Baldeshwiler, Andrea, Abner, Erin L., Bauer, Björn, Hartz, Anika M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937299/ https://www.ncbi.nlm.nih.gov/pubmed/33676539 http://dx.doi.org/10.1186/s12987-021-00245-4 |
Ejemplares similares
-
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
por: Vulin, Milica, et al.
Publicado: (2023) -
Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
por: Hartz, Anika M. S., et al.
Publicado: (2018) -
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
por: Schulz, Julia A., et al.
Publicado: (2023) -
ABC Transporters and the Alzheimer’s Disease Enigma
por: Wolf, Andrea, et al.
Publicado: (2012) -
A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice
por: Wolf, Andrea, et al.
Publicado: (2016)